Columbus Weekly report on share buyback
Company announcement no. 39/2025 Transactions in the period 8 December 2025 to…
Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
– Company to host live webcast and conference call Monday, December 15,…
Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods
BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian…
Mutuum Finance (MUTM) Completes Smart Contracts in Preparation for Q4 2025 Testing
Dubai, UAE, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a…
Free Spins No Deposit Casino | Real Money Online Casino No Deposit Bonus By Cafe Casino
New York City, NY, Dec. 13, 2025 (GLOBE NEWSWIRE) -- . Free…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
Accelerating Patient Recruitment and Research Excellence: TrialWire Supports Endpoints Clinical Trials Day NYC 2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest,…
New Crypto Coin Mutuum Finance (MUTM) Nears 100% of Phase 6 Allocation as Investor Activity Accelerates
Dubai, UAE, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a…
Fobi AI Announces Partial Revocation Order and Non-Brokered Private Placement
Not for distribution to U.S. news wire services or dissemination in the…
Genesis Healthcare Remains Committed to Securing Longterm Stability
KENNETT SQUARE, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Following a court…